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The luminal membrane of rat thick limb expresses AT1 receptor Angiotensin II (Ang II) contributes to the regulation
and aminopeptidase activities. of extracellular fluid volume mainly through its stimula-
Background. Endogenous intratubular angiotensin II (Ang II) tory effect on aldosterone secretion, which increasessupports an autocrine tonic stimulation of NaCl absorption in
NaCl reabsorption by cortical collecting duct. Ang II alsothe proximal tubule, and its production may be regulated inde-
exerts several more direct effects on the kidney, mainlypendently of circulating Ang II. In addition, endogenous Ang II
activity may be regulated at the brush border membrane (BBM), via Ang II subtype 1 receptors (AT1-R) that are widely
by the rate of aminopeptidase A and N (APA and APN) ac- distributed in renal vessels and all along the renal tubule
tivities and the rate of Ca2-independent phospholipase A2 [1, 2]. Ang II influences the NaCl urinary excretion rate(PLA2-dependent endocytosis and recycling of the complex
through its hemodynamic effects on the glomerular fil-Ang II subtype 1 (AT1) receptor (AT1-R). The aim of the pres-
ent study was to look for subcellular localization of AT1-R, tration rate (GFR), renal medullary blood flow, as well
and APA and APN activities in the medullary thick ascending as direct effects on NaCl reabsorption in the proximal
limb of Henle (mTAL), as well as search for an asymmetric
tubule [3]. Ang II also participates in the renal regulationcoupling of AT1-R to signal transduction pathways.
of acid-base balance by stimulating HCO3 absorptionMethods. Preparations of isolated basolateral membrane
(BLMV) and luminal (LMV) membrane vesicles from rat mTAL and influencing ammonium production and secretion in
were used to localize first, AT1-R by 125I-[Sar1, Ile8] Ang II bind- the proximal tubule [4, 5]. Systemic infusion of a physio-
ing studies and immunoblot experiments with a specific AT1-R logic, non-pressor dose of Ang II corresponding to theantibody, and second, APA and APN activities. Microfluoro-
pmol/L plasma concentration of the hormone enhancesmetric monitoring of cytosolic Ca2 with a Fura-2 probe was
performed in mTAL microperfused in vitro, after apical or proximal NaCl, fluid and HCO3 absorption. Ang II also
basolateral application of Ang II. is endogenously produced and secreted by proximal tu-
Results. AT1-R were present in both LMV and BLMV, with bule cells, accounting for higher (nmol/L) and stablea similar Kd (nmol/L range) and Bmax. Accordingly, BLMV and intratubular concentration, likely maintained by the bal-LMV preparations similarly stained specific AT1-R antibody.
ance between hormone production and degradation byAPA and APN activities were selectively localized in LMV,
although to a lesser extent than those measured in BBM. In aminopeptidases and neutral endopeptidase highly ex-
the in vitro microperfused mTAL, basolateral but not apical pressed at the brush-border membranes (BBM) [6–8].
Ang II induced a transient increase in cytosolic [Ca2].
This locally produced intratubular Ang II seems to beConclusions. Besides the presence of basolateral AT1-R in
independent of variations of circulating Ang II, and toni-mTAL coupled to the classical Ca2-dependent transduction
pathways, AT1-R are present in LMV, not coupled with Ca2 cally supports NaCl, fluid and HCO3 absorption in the
signaling, and co-localized with APA and APN activities. Thus, proximal tubule via autocrine mechanisms, which sug-
apical APA and APN may play an important role in modulating
gests a role of intratubular Ang II in the glomerulo-tubularendogenous Ang II activity on NaCl reabsorption in mTAL.
balance [6, 8–10]. By both binding studies and immuno-
histochemical methods, AT1-R clearly have been shownKey words: angiotensin II, AT1 receptor, thick ascending limb, kid- to be present on both basolateral and luminal membranesney, aminopeptidases A and N, extracellular fluid, sodium chloride
handling. of proximal tubule [1, 11–13], with asymmetric signal
transduction pathways. The most commonly reported sig-
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cling of Ang II–AT1-R complex, which involves a Ca2- these enzymes might play an important role in modu-
lating the effect of intra tubular endogenous Ang II onindependent phospholipase A2 (PLA2) pathway [16–18].
Much less is known about the Ang II effects and their NaCl absorption in mTAL.
mechanisms in tubule segments beyond the proximal
tubule, particularly in the thick ascending limb (TAL).
METHODS
AT1-R are present in TAL [1, 11, 19, 20], but the subcellu-
Animalslar localization in basolateral versus apical membranes
of cells is not established. Some studies indirectly suggest Male Sprague-Dawley rats weighting 250 to 300 g and
maintained on a standard rodent laboratory diet (UARthat Ang II may stimulate NaCl absorption in TAL.
In microdissected rat cortical TAL (cTAL) segments, Epinay sur Orge, France) and free access to tap water
were used in these studies.addition of Ang II to the medium stimulates the furo-
semide-sensitive metabolic production of CO2 that is an
Preparation of mTAL tubulesindirect indicator of NaCl absorption (abstract; Hus-
Citharel et al, J Am Soc Nephrol 11:422A, 2000). In medul- Highly purified mTAL suspension was prepared ac-
cording to the previously described method [26, 27].lary TAL (mTAL) suspensions, adding Ang II to the
medium stimulates apical Na-K(NH4)-2Cl cotrans- Briefly, fasting animals were anesthetized with pentobar-
bital sodium. Kidneys were removed quickly, decapsu-port (BSC1 or NKCC2) [21] and K channels [22], which
are both involved in NaCl absorption. Most of these lated and sliced sagitally. Slices were transferred in Hank’s
modified medium, and the inner stripe of the outer me-effects are suppressed by losartan, suggesting the role
of AT1-R. No data are available about the effects of dulla was carefully excised under stereomicroscopic con-
trol. The resulting tissue was subjected to collagenasebasolateral or apical application of Ang II on the trans-
epithelial NaCl absorption in TAL. Moreover, amino- treatment (0.4 mg/mL) followed by a low speed centrifu-
gation to discard digested tubules and isolated cells. Thepeptidases A and N (APA and APN) are ectoenzymes
responsible for the conversion of Ang II to Ang III, and final suspensions as observed in light microscopy con-
tained almost exclusively mTAL fragments, occasionalof Ang III to Ang IV, respectively. APN is also one
of the main enzymes degrading Ang IV into smaller thin descending limb fragments, and no isolated cells and
medullary collecting duct as observed by others [27]. Vir-peptides. APA is present in TAL [23], but its subcellular
localization is not known. In addition, if APN is clearly tually all the tubule fragments were shown to be stained
by indirect immunofluorescence against Tamm-Horsfallexpressed in brush border membranes of proximal tu-
bule in the cortex [24], its expression in thick ascending protein [26], a specific marker for TAL. For intracellular
calcium measurements, special cautions were taken tolimb remains to be established. These questions are of
importance: Ang III has an effect similar to Ang II via limit the total duration of collagenase treatment below
60 min.AT1-R, and Ang IV may have opposite effects to Ang II
on NaCl absorption in renal tubule [25] via AT4-R pres-
Preparation of largely purified luminal andent in mTAL (abstract; Poumarat et al, J Am Soc Nephrol
basolateral mTAL membranes12:A2990, 2001). Finally, few data are available about
the AT1-R signal transduction in TAL, and the possible Typically, the preparation began with approximately
15 to 20 mg protein of mTAL tubules obtained frompresence of asymmetric cellular transduction pathways
(as in the proximal tubule) has not been tested to date. 12 rats. Both types of plasma membrane vesicles were
isolated simultaneously by a combination of Ca2 aggre-The present study was designed to examine subcellular
localization of AT1-R, and APA and APN enzymatic ac- gation, differential and density gradient centrifugations,
as previously described in detail [26]. As compared withtivities in rat by using preparations of isolated mTAL
basolateral and apical membranes. In addition, in vitro the homogenate, Na,K-ATPase activity, a basolateral
marker, was enriched 6.5-fold in the basolateral mem-microperfused mTAL studies were performed to test
whether an asymmetric coupling of AT1-R to transduc- brane vesicle (BLMV) and only 0.7-fold in the luminal
membrane vesicle (LMV), whereas -glutamyltransfer-tion pathways was present.
We demonstrated the presence of AT1 type binding ase, an LMV marker, was enriched approximately ten-
fold in the LMV and twofold in the BLMV. It was pre-sites on both basolateral and apical membranes of mTAL
with similar Kd and Bmax values, as well as the presence viously established that sealed vesicles (84% of LMV and
30% of BMLV) were oriented right side out [28]. Previ-of AT1-R protein. We also showed that APA and APN
activities are selectively present at the luminal mem- ous data clearly established that LMV and BLMV reflect
properties of luminal and basolateral mTAL membranes,branes of mTAL. Basolateral but not luminal application
of Ang II is able to induce a transient increase in intracel- respectively. For example, LMV selectively express Na-
K-2Cl activity and Na/H exchange-3 (NHE-3) pro-lular Ca2. The colocalization of AT1-R and APA/APN
activities in the apical membrane of mTAL supports that tein [26, 29]. BLMV selectively express pH sensitive Cl/
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HCO3 type 2 anionic exchanger (AE2), NHE-1 and Chemie, Diesenhofen, Germany) was used to determine
approximate molecular weight. Electrophoresis was car-NHE-4 Na/H exchanger proteins [26, 30, 31].
ried out at 200 V for 90 minutes. Proteins were then
Brush-border membrane preparations transferred at 100 V for 60 minutes to a nitrocellulose
membrane (0.45 mm; Schleider & Schuell, Keene, NH,Brush-border membranes (BBM) were isolated from
superficial cortex homogenate by a method of Ca2 ag- USA). Nitrocellulose membranes were stained with red
Ponceau coloration to visualize protein bands. Nonspe-gregation and differential centrifugation as previously
described [32]. They were appropriately enriched with cific binding sites were blocked by incubation of the
blots for 90 minutes at room temperature in phosphate--glutamyltransferase (11-fold) as compared to homoge-
nate, and were de-enriched in the Na,K-ATPase activ- buffered saline (PBS) containing 5% fat-free milk, 0.2%
Tween. Incubation with the primary antibody was per-ity (0.5-fold; data not shown).
formed overnight at 4C in PBS containing 2.5% fat-free
Binding assay milk, 0.2% Tween. The blot was subsequently washed
four times in PBS-0.2% Tween. After the washings, theBinding experiments were performed with 0.1 nmol/L
125I-[Sar1, Ile8] Ang II and a variable amount of unlabeled blot was incubated with the secondary antibody conju-
gated to horseradish peroxidase [goat anti-rabbit immu-peptide or non-peptide ligand. To prevent peptide degra-
dation, in general a 4 L protein aliquot (10 to 20 g noglobulin G (IgG) from Bio-Rad] for 90 minutes at
room temperature, followed by four ten-minute washes.protein) of either BLMV or LMV was added to 80 L
incubation medium containing: 50 mmol/L HEPES/Tris Equal volumes of detection reagents 1 and 2 provided
for enhanced chemiluminescence Western blotting were(pH 7.40), 150 mmol/L NaCl, 3 mmol/L egtazic acid
(EGTA), 0.1 nmol/L 125I-[Sar1, Ile8] Ang II, and 0.5% added (ECL kit; Amersham, Braunschweig, Germany).
Detection was accomplished by incubation of the blotbovine serum albumin (BSA) as well as a commercial
cocktail protease inhibitor (Complete mini; Roche Diag- with this mixture for one minute. After the excess fluid
was drained, the blot was covered with plastic wrap andnostic, Meylan, France) and 1 mmol/L phenanthroline.
Initial experiments established that binding equilibrium exposed to x-ray film (Kodak, Merck-Eurolab, Darm-
stadt, Germany).was reached between 90 and 120 minutes at room tem-
perature, and that freezing membranes lead to a drastic The AT1 receptor antibody used was directed against
the 15-24, amino terminal extracellular domain peptide,(50%) decreased in the binding. Thus, the incubation
of freshly prepared membranes was conducted at room and while specific for the AT1 receptor, it was unable to
distinguish between the AT1A and AT1B receptors [11].temperature during 105 minutes. Incubation was termi-
nated by vacuum filtration on the center of a 0.45 m
Aminopeptidase assayspre-wetted Millipore cellulose filter (HAWP) presoaked
in a 4 mg/mL BSA for four hours. The filters were washed Aminopeptidase A (APA) and aminopeptidase N
(APN) activities were estimated by measuring the hy-four times with 4 mL ice-cold Tris buffer containing in
mmol/L, 50 HEPES/Tris, 150 NaCl, pH 7.40, and 0.5 drolysis of synthetic substrates, -l-glutamyl- naph-
tylamide (for APA) or l-alanine- naphtylamide (formg/mL BSA. For all experiments, nonspecific binding
to filter and membranes was defined in the presence of APN). Briefly, membranes of either BLMV, LMV or
BBM (final protein concentration 10 to 20 g/mL) from10 mol/L of unlabeled Ang II with appropriate blanks
and subtracted from values of the incubated samples. at least three independent experiments were incubated
at 37C in a medium pH 7.40 containing (in mmol/L):The filters were dissolved in 3 mL of scintillate (Filter-
Count; Packard Instruments, Downer’s Grove, IL, USA), 150 NaCl, 50 HEPES/Tris, 4 CaCl2 and 200 mol/L of
the appropriate substrate. The reaction was stopped byand radioactivity was measured in a liquid scintillation
spectrometer. the addition of HCl 3N. The amount of naphthylamine
issued from substrate hydrolysis was quantified after suc-
Western blot analysis of cortical and mTAL cessive addition of NaNO2, ammonium sulfamate and
AT1 receptors then N-(1-naphthtyl)-ethylenediamine dihydrochloride.
The absorbency was monitored at 560 nm. CalibrationAliquots of membrane preparations were assayed for
protein concentration by the method of Bradford [33]. was obtained from absorbency of standard naphtylamine
solutions (0.8 mol/L to 50 mol/L). Enzymatic activi-Protein extracts from three independent experiments
were processed for immunoblotting as previously de- ties were expressed in nmol -naphthylamine · min1 ·
mg1 protein. For specific APA activity determination,scribed [26]. Aliquots (10 to 20 g proteins) were sepa-
rated by 4 to 7.5% stacking sodium dodecyl sulfate- experiments were performed in the absence or presence
of EC33 (3-amino-4-mercaptobutyl sulfonate), a specificpolyacrylamide gel electrophoresis (SDS-PAGE; Bio-Rad
Laboratories, Richmond, CA, USA). A prestained mo- APA inhibitor [34]. All APA experiments were performed
in the presence of 1mol/L Bestatin, a non-specific amino-lecular weight mixture of 32 to 200 kD (Sigma Aldrich
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peptidase inhibitor, in order to prevent the degradation sels, Belgium) used in this part of the study had free
access to standard rat chow and distilled water until theof the substrates by other aminopeptidases such as B,
N, W or cytosolic leucine aminopeptidases [35, 36]. At time of experiments. Animals were injected IP with furo-
semide (2 mg), 10 minutes before being anesthetizedthis concentration, Bestatin does not inhibit APA activ-
ity [37]. Specific APA activity was defined by the EC33- with sodium pentobarbital (50 mg/kg BW). Both kidneys
were cooled in situ with control bath solution for onesensitive activity [23].
minute and then removed and cut into thin coronal slices
Measurements of cytosolic-free calcium in fresh for tubule dissection. Medullary thick ascending limbs
mTAL tubule suspension were dissected from the inner stripe of the outer medulla
at 4C in the control solution of the experiment. TheThe method used for measuring intracellular calcium
concentration ([Ca2]i) was derived from one previously isolated tubule was transferred to the bath chamber on
the stage of an inverted microscope (Axiovert 100; Carldescribed [15]. For these experiments, the mTAL tubule
suspension was resuspended in a Hank’s modified me- Zeiss, Jena, Germany), mounted on concentric pipettes
and perfused in vitro. To prevent motion of the tubuledium containing, in mmol/L: 112 NaCl, 0.3 Na2HPO4, 5.4
KCl, 0.44 KH2PO4, 0.4 MgSO4, 0.5 MgCl2, 1.5 CaCl2, 10 during intracellular calcium measurement, the average
tubule length exposed to bath fluid was limited to 300HEPES, 25 NaHCO3, 5 glucose, 5 leucine, 5 pyruvate,
2.5 (lactate)2 Ca, 1 Na3citrate and 0.1% fatty acid-free to 350 m.
Solution composition. The composition of the solu-BSA. Tubules were loaded with the calcium sensitive
dye, by incubation for 50 minutes at room temperature in tion was (in mmol/L): 112 NaCl, 0.3 Na2HPO4, 5.4 KCl,
0.44 KH2PO4, 0.4 MgSO4, 0.5 MgCl2, 1.5 CaCl2, 10Hank’s modified medium supplemented with 4 mol/L
Fura-2/AM (Fura-2; prepared as a 20-mmol/L stock in HEPES, 25 NaHCO3, 5 glucose, 5 leucine, 5 pyruvate,
1.25 (lactate)2Ca, and 1 Na3citrate. The solutions wereDMSO; Molecular Probes, Leiden, The Netherlands),
250 mol/L adenosine 5	 triphosphate (ATP) Tris, and continuously gassed with 95% O2/5% CO2 at 37C. Be-
fore each experiment, Na, K and Cl concentrations,gassed with 95% O2/5% CO2, pH 7.40. Following Fura-2
loading, the suspension was rinsed, resuspended in osmolality, and pH were measured in bulk solutions.
Ang II (100 nmol/L) was added to the luminal or peritu-Hank’s modified medium supplemented with 4 mol/L
Fura-2/AM gassed with 95% O2/5% CO2, pH 7.40, and bular fluid, as appropriate.
Cytosolic calcium [Ca2]i measurement. Medullary thickkept at 4C until use. For measurements, suspension
samples were washed three times at 37C in 2 mL of ascending limbs cells were loaded with the fluorescent
probe by exposing the cells for approximately 60 minutesHank’s modified medium in order to remove extracellu-
lar dye, resuspended in 200 L and then injected into at room temperature to the bath solution containing 20
mol/L Fura-2 acetoxy methylester. Loading was contin-cuvettes containing 1.2 mL of Hank’s medium. Fluores-
cence of the dye was alternatively measured at two exci- ued until the fluorescence intensity at 340 nm excitation
was at least one order of magnitude higher than thetation wavelengths, 340 and 380 nm with constant emis-
sion of 495 nm, using a Jobin Yvon spectrofluorometer background fluorescence. The loading solution was then
washed out by initiation of bath flow and the tubule(Lonjumeau, France), equipped with water-jacketed,
temperature-controlled cuvette holder. Tubules were was equilibrated with dye-free bath solution for 5 to 10
minutes. Bath solution was delivered at a rate of 20 mL/continuously magnetically stirred and gassed with 95%
O2/5% CO2. The internal delay between changing excita- min and warmed to 37
 0.5C by a water jacket immedi-
ately upstream to the chamber. The perfusion rate wastion wavelengths was short enough to permit an accurate
determination of the course of change in [Ca2]i. At the adjusted by hydrostatic pressure to approximately 20
nL/min to prevent axial changes in the composition ofend of each measurement, the extracellular Fura-2 was
estimated with 5 mmol/L EGTA. Then, successive addi- luminal fluid.
Intracellular dye was excited alternatively every 2 sec-tions of 90 mmol/L Tris, 6.5 mol/L digitonin, and 5.5
mmol/L CaCl2 allowed calibration of the signal to be onds at 340 and 380 nm with a 75-watt Xenon lamp and
a computer-controlled chopper assembly. Emitted lightperformed. After correction for autofluorescence, the
ratios 340/380 were obtained, converted into [Ca2]i us- was collected through a dichroı¨c mirror, passed through
a 510 nm filter and focused onto a CCD camera (ICCDing the formula of Grynkiewicz et al and dissociation
constant (Kd) of Fura-2/Ca2 of 224 nmol/L at room 2525F; Videoscope International, Sterling, VA, USA)
connected to a computer. The measured light intensitiestemperature [38]
were digitized with 8-bit precision (256 gray level scale)
Measurements of cytosolic free calcium in mTAL for further analysis. For each tubule, a region of interest
tubule microperfused in vitro was drawn and the mean gray level for each excitation
wavelength was calculated with the Starwise Fluo soft-Tubule isolation and perfusion. Pathogen-free male
Sprague-Dawley rats (60 to 75 g BW; Iffa Credo, Brus- ware (Imstar, Paris, France). Background fluorescence
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Fig. 1. Binding 125I-[Sar1, Ile8]-Ang II (0.1
nmol/L) was measured at room temperature
in luminal (LMV, A) and basolateral (BLMV,
B) membrane vesicles from a suspension of
medullary thick ascending limb (mTAL) tu-
bules. Binding was measured in the absence
(total binding, ), or in the presence of 105
mol/L angiotensin II (Ang II) to determine
non-specific binding (). Specific binding ()
was obtained by difference between total and
non-specific binding. Each point is mean 

SEM of at least two independent experiments
in duplicate.
was subtracted from fluorescence intensity at each excita- minutes in both membranes (data from 3 independent
experiments, individual points are mean of at least 4tion wavelength to obtain intensities of intracellular flu-
orescence. The 340-nm to 380-nm ratio was used as an experimental values). Non-specific binding was less than
5% of total binding. Thus, the subsequent incubationsindicator of cytosolic calcium concentration.
lasted 105 minutes at room temperature.
Chemicals The results from saturation binding experiments and
Scatchard plots are shown in Figure 2. In both mem-125I-[Sar1, Ile8] Ang II was obtained from NEN (Life
branes, 125I-[Sar1, Ile8]-Ang II bound in a saturable man-Science products, Zaventem, Belgium). Fura-2/AM from
ner to a single class of high-affinity binding sites. TheMolecular Probes Inc. (Eugene, OR, USA). -l-gluta-
apparent Kd values were similar in both membranes (Kdmyl- naphtylamide, l-alanine- naphtylamide [Sar1,
0.9 
 0.4 vs 1.4 
 0.6 nmol/L, BLMV vs LMV; NS). TheIle8] Ang II, human Ang III, human Ang II (1-7), [Sar1,
estimated numbers of sites were similar in both prepara-Ile7] Ang III, Ang IV, CGP 42112 A or Nicotinoyl-Tyr-
tions (Bmax 239 
 23 vs. 170 
 18 fmol · mg protein1;Lys(Z-Arg)-His-Pro-Ile-OH were from Bachem (Buben-
dorf, Switzerland). Human Ang II, phenanthroline, BLMV vs. LMV; NS).
bestatin, were from Sigma (Sigma-Aldrich Chimie, St. To precisely measure the specificity of the binding,
Quentin Fallavier, France). Complete and collagenase competition experiments were performed with 0.1 nmol/L
A were from Roche Diagnostics (Meylan, France). Lo- 125I-[Sar1, Ile8]-Ang II and variable amounts of Ang II
sartan was a gift from Dupont Nemours. fragments. All competition curves were best fitted with
a single-site-binding model. As detailed in Table 1, and
Statistical analyses partly shown in Figure 3, the order of potency of Ang II,
All of the results are mean values of replicate sam- Sar derivatives and Ang II fragments as competitors was
ples 
 SEM. Statistical differences were assessed using similar in LMV and BLMV, and as follows: [Sar1, Ile8]
the t test for unpaired data. The median effective concen- Ang IIAng IIAng IIIAng II (1-7)Ang IV. Of
tration (EC50) and median inhibitory concentration (IC50) note, in LMV (but not in BLMV) Ang II was apparently
were estimated by fitting the data to a non-linear regres- less potent than [Sar1, Ile8]-Ang to compete with 125I-
sion model (least squares criterion) using commercially [Sar1, Ile8]-Ang II binding, with an apparent Kd one log
available software (Prism; Graphpad Software, San Diego, range lower for [Sar1, Ile8] Ang II than for Ang II. Be-
CA, USA). cause [Sar1, Ile8] Ang II is less sensitive than Ang II to
aminopeptidase degradation, these results probably re-
flect a selective residual degradation of Ang II. This
RESULTS
degradation essentially occurred in LMV in spite of the
Binding of 125I-[Sar1, Ile8]-Ang II to plasma presence of inhibitors, because these membranes expressed
membrane vesicles from mTAL (as demonstrated below) aminopeptidase activities.
To distinguish between AT1-R and AT2-R, the effectsBinding studies were first addressed to test whether
125I-[Sar1, Ile8]-Ang II bound to basolateral (BLMV) and of specific AT1-R and AT2-R inhibitors as well as mmol/L
range dithiothreitol (DDT) concentrations on 125I-[Sar1,luminal membranes (LMV) in a specific manner, and to
determine the time needed to reach binding equilibrium. Ile8]-Ang II binding were studied.
The effects of AT1-R and AT2-R inhibitors on theMembranes were incubated in the presence of protease
inhibitors (see Methods) at room temperature with 0.1 binding of 125I-[Sar1, Ile8]-Ang II are presented in Table 1.
In both preparations, 106 mol/L losartan, a well-knownnmol/L 125I-[Sar1, Ile8]-Ang II. As shown in Figure 1, spe-
cific binding equilibrium was reached between 90 and 120 AT1 antagonist, totally inhibited the binding (IC50 17.6
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Fig. 2. Saturation binding experiments and
Scatchard transformation (inset) for 125I-[Sar1,
Ile8]-Ang II (0.1 nmol/L) in luminal () and
basolateral () membranes purified from a
suspension of mTALs. These data best de-
scribe a single-site affinity in LMV (Kd  0.9
nmol/L, Bmax  239 fmol/mg protein), and
BLMV (Kd  1.4 nmol/L, Bmax  170 fmol/mg
protein). Each point is mean 
 SEM of 3
independent experiments in duplicate.
Table 1. Binding constants for Ang II–related compounds derived from competition curves with 125I [Sar1,Ile8]-Ang II in luminal (LMV)
and basolateral (BLMV) membranes isolated from medullary thick ascending limb tubule suspension
BLMV LMV
Competitor Kd n, N
Amino-terminal deletion of Ang II
Ang II 5.8
0.6 109 mol/L 33
3 109 mol/L 66, 4
Ang III 17
2 109 mol/L 35
6 109 mol/L 32, 3
Ang IV 105 mol/L 105 mol/L 12, 2
Carboxy-terminal deletion of Ang II
Ang (1-7) 1.2
0.2 106 mol/L 5.8
0.7 106 mol/L 12, 2
Angiotensin receptor antagonists
Losartan 17.6
4.2 109 mol/L 28.0
3.6 109 mol/L 32, 3
PD 123 177 104 mol/L 104 mol/L 12, 3
CGP 41122A 104 mol/L 104 mol/L 12, 3
[Sar1,Ile8]-Ang II 5.1
1.1 109 mol/L 2.6
0.6 109 mol/L 36, 3
[Sar1,Ile7]-Ang III 28
6 109 mol/L 44
13 109 mol/L 21, 2
Data are mean 
 SD; n is the number of individual values used for the fits, issued from N independent experiments.
Fig. 3. Competition experiments on 125I-[Sar1,
Ile8]-Ang II (0.1 nmol/L) binding in basolat-
eral (BLMV, A) and luminal (LMV, B) mem-
branes from mTAL tubules suspension on 125I-
[Sar1, Ile8]-Ang II binding (0.1 nmol/L). In-
creasing concentration of () [Sar1, Ile8]-Ang
II, () Ang II, () Ang III, () Ang II (1-7),
and () Ang IV were added to incubation
medium. All data best fit with a single-site
competitive curve. Each point is mean
 SEM
of 3 experiments performed in duplicate.
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Table 2. Aminopeptidase A (APA) and N (APN) activities
measured in homogenates, luminal (LMV) and basolateral
(BLMV) membrane vesicles from mTAL suspension
compared with those measured in homogenate and
brush-border membranes (BBM) from kidney cortex
APA APN
nmol · mg protein1 · min1
mTAL suspended
Fig. 4. Immunoblot experiments were performed with 10 g of either Homogenate 12.7
3.4 44.2
11.7
luminal and basolateral membrane from mTAL (lanes 1 and 2, respec- LMV 107.7
13.6 364.3
50.3
tively), or homogenate and brush border membranes from superficial BLMV 11.9
3.1 24.4
2.7
cortex (lanes 3 and 4, respectively). All membranes stained specific Superficial cortex
AT1-R antibody. The 45 kD band correspond to the expected form of Homogenate 116.5
1.75 248.5
8.5
non-glycosylated AT1-R. A faint additional 65 kD band also is present BBM 1291.5
22 2502.5
643
in all preparations, usually reported as glycosylated form of AT1-R, but
Values are mean 
 SEM from at least 3 independent experiments.seen in LMV and BLMV only with prolonged exposure (not shown
here).
APA and APN activities in plasma membrane vesicles
4.2 109 mol/L vs. 28.0
 3.6 109 mol/L, BLMV vs. LMV, Aminopeptidases A and N activities were first mea-
NS). By contrast, two AT2 inhibitors, the CGP 42112 A sured in homogenates, LMV and BLMV issued from three
and PD 123319, were unable to specifically inhibit 125I- independent mTAL suspensions. Because -l-glutamyl-
naphtylamide is not a highly specific substrate of APA,[Sar1, Ile8]-Ang II binding to LMV and BLMV (IC50 
the experiments were repeated in the presence of a105 mol/L for both antagonists in both membranes).
highly selective APA inhibitor, the EC-33 (3-4 amino-The effect of pre-incubation with DTT, a sulfhydryl-
thiol butyl sulfonate) produced by the Structural andreducing agent, was then studied. At a mmol/L range
Molecular Pharmacochemistry Unit of INSERM U266concentration, this compound is known either to have
[34]. APA activity was then defined as the EC-33–sensitiveno effect or stimulate (AT2-R) or inhibit (AT1-R) Ang II
activity. As shown in Table 2, both APA and APN activi-binding [39]. In both LMV and BLMV membranes, an
ties were present in mTAL homogenates. These activi-addition of mmol/L range DTT concentration in the bind-
ties were selectively enriched in LMV (enrichment factoring incubation medium induced a drastic decrease in 125I-
0.85 vs. 8.5 for APA, 0.55 vs. 8.2 for APN, BLMV vs.
[Sar1, Ile8]-Ang II binding (IC50 4.7 vs. 5.4 mmol/L, LMV LMV). These data suggested selective luminal expres-
vs. BLMV, NS). sion of aminopeptidase activities. APA and APN activi-
Altogether these data suggest the presence of AT1 ties in mTAL homogenates and in LMV membranes
type but not AT2 type receptors in both luminal and were then compared to those measured in homogenates
basolateral membrane preparations from a mTAL sus- and BBM issued from three independent superficial cor-
pension. tex preparations. As also shown in Table 2, APA and
APN activities measured in superficial cortex homoge-
Immunoblot studies of plasma membranes with nates were about 10 and 5 times higher than those mea-
AT1-R specific antibody sured in mTAL homogenates. In agreement, APA/APN
activities measured in BBM were about 10 and 5 timesWestern blot analyses were performed with AT1-R
higher than those measured in LMV membranes.specific antibody to confirm that both mTAL membranes
Because BBM and LMV preparations offered theexpress AT1-R protein. Homogenates and luminal mem-
unique opportunity to characterize cortical and mTALbranes (BBM) from cortex were used as controls.
APA activities, additional studies were performed. Ac-Figure 4 shows that both BLMV and LMV vesicles
cording to the previously reported data [40], APA activ-expressed AT1-R protein. Indeed, Western blot analysis ity in LMV and BBM were highly sensitive to extracellu-
for the AT1-R in all preparations showed a band with lar calcium concentration. Indeed, while APN activity
an estimated molecular weight of 45 kD, consistent with was only marginally stimulated (less than 2-fold) in the
the predicted molecular weight from the cDNA sequence presence of calcium, APA was stimulated about fourfold
for the nonglycosylated form of the AT1-R. A faint 65 kD in the presence of 4 mmol/L CaCl2 as compared to a
band described as glycosylated forms of AT1-R was found, zero calcium condition.
as previously reported, in cortex homogenate and BBM The luminal Ang II concentration was probably lower
[11]. This band also was present at a lesser degree in in mTAL than in proximal tubule. Thus, we thought it
LMV and BLMV, however, it was only seen with pro- would be interesting to test whether APA activity had
an identical or higher affinity in LMV than in BBM. Thelonged film exposition.
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Fig. 5. Aminopeptidase A (APA) activity, es-
timated from the hydrolysis of -l-glutamyl-
-naphtylamide in the presence and absence
of EC-33, a specific APA inhibitor, in function
of substrate concentration in luminal mem-
branes from mTAL (LMV) and in brush bor-
der membranes from superficial cortex (BBM).
APA activity was defined as the EC-33-sensi-
tive activity. Data are mean 
 SEM of 3 in-
dependent experiments in duplicate. Symbols
are: () total; () EC-33 insensitive; ()
EC-33 sensitive.
Fig. 6. Effect of acute addition in the medium
of increasing concentrations of Ang II on in-
tracellular calcium concentration ([Ca2]i) in
mTAL tubule suspension. (A and B) Repre-
sentative experiments on the effect of 107
mol/L Ang II on [Ca2]i in the absence and
presence of losartan (106 mol/L), respec-
tively. (C ) Concentration-dependent [Ca2]i
peak response to Ang II (% of basal value).
(D) Concentration-dependent inhibition of
losartan, a selective AT1-R inhibitor, on the
Ang II-induced increased in [Ca2]i. In the
latter experiments, Ang II was used at its max-
imal effective dose (107 mol/L). In panels C
and D, each point is the mean 
 SEM of at
least 3 experiments performed in duplicate.
Michaelis Menten analysis demonstrated similar affinit- tionship between Ang II concentration and increase in
intracellular Ca2 (measured at the peak) is shown in Fig-ies for the substrate in both membranes (125 vs. 145
mol/L; LMV vs. BBM; Fig. 5). These data suggested ure 6C. A half-maximum response (EC50) was obtained
for 1.2 nmol/L Ang II, and a maximal response for 107that APA expressed in BBM and LMV were not func-
tionally different. mol/L Ang II. As shown in Figure 6 B and D, losartan,
a specific AT1 antagonist, exerted no effect on the basal
[Ca2]i response induced by Ang II in mTAL [Ca2]i value, but in a dose-dependent manner inhibited
tubules suspension the effect of 107 mol/L Ang II (apparent IC50  3.107
mol/L).The presence of AT1-R in mTAL cells led us to charac-
terize in tubular suspensions the dose-dependent in-
Basolateral but not luminal Ang II applicationcrease in intracellular calcium concentration in response
induced [Ca2]i response in mTALto acute application of Ang II, as a reflection of Ca2
microperfused in vitropathway activation. Acute addition in incubation me-
dium of Ang II induced within 6 seconds an acute in- Experiments performed in mTAL suspension did not
allow the luminal versus basolateral effect of Ang II oncrease in [Ca2]i. This peak response was followed by a
gradual decline in [Ca2]i to a plateau value which re- the Ca2 pathway activation to be distinguished. Thus,
additional experiments were performed in microdis-mained higher than control values (Fig. 6A). The rela-
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sence of the inhibitor. Subsequent basolateral applica-
tion of 107 mol/L Ang II induced a transient increase
in intracellular calcium that was similar to that previously
observed. These data suggested that the lack of luminal
effect of Ang II was not related to any toxic effect of
GluPO3H2.
Altogether, these data suggested that the asymmetric
response to Ang II in the in vitro microperfused mTAL
was not due to selective luminal degradation of Ang II
into inactive fragments. Rather, the lack of a luminal Ang II
effect on intracellular calcium likely reflects the lack of
luminal AT1-R coupling to Ca2 pathway activation.
DISCUSSION
There are three primary novel findings in the present
study. First, rat medullary thick ascending limb (mTAL)
cells express AT1 receptors (AT1-R) at both basolateral
and luminal membranes, with high apparent affinity simi-
lar to that reported in basolateral and luminal mem-
branes from proximal tubules (Kd in the nmol/L range).
Second, aminopeptidases A and N (APA and APN)
activities are selectively localized at the luminal mem-Fig. 7. Effect of acute application of 107 mol/L Ang II at the luminal
side and then the basolateral side of microdissected mTAL microper- brane of mTAL. Finally, basolateral but not luminal
fused in vitro. In the represented experiment, luminal application of AT1-R are coupled to intracellular calcium signaling107 mol/L Ang II was performed in the presence of 5 107 mol/L of
pathway.GluPO3H2, a potent APA inhibitor, in the luminal perfusate. Similar
results were observed in the absence of the inhibitor. Representative The mTAL plays an important role in sodium, water
experiment performed in triplicate. and acid-base homeostasis [43]. The presence of AT1
receptors (AT1-R) indicates that this segment is a target
site for angiotensin II (Ang II) [2, 11, 20]. Because Ang II
is present in high (nmol/L range) concentration in proxi-sected mTAL microperfused in vitro. The variations in
mal tubule lumen and in post glomerular star vesselscytosolic calcium concentrations in response to basolat-
(versus low pmol/L range concentrations in systemic cir-eral and luminal Ang II applications were compared.
culation), Ang II is likely present at significant concentra-As expected, an acute addition of 107 mol/L Ang II
tion at both basolateral and luminal sides of mTAL epi-in the bath induced a transient increase in intracellular
thelium [6, 7].calcium concentration. This effect was totally inhibited in
We established from both binding studies and immu-the presence of 106 mol/L losartan. By contrast, luminal
noblot experiments the presence of AT1-R on largelyapplication of 107 mol/L Ang II failed to induce any in-
purified basolateral (BLMV) and luminal (LMV) mem-crease in intracellular calcium (not shown), even at a
brane vesicles from MTAL. Binding studies on LMVhigh perfusion rate (20 nL/min) to limit the rate of degra-
and BLMV used 125[Sar1, Ile8]-Ang II, which is more re-dation of Ang II by peptidases. However, because amino-
sistant to aminopeptidases than Ang II. These experi-peptidases are very efficient enzymes, degradation of
ments showed similar high affinity AT1-type sites (Kd 1Ang II into inactive fragments during luminal Ang II
to 2 nmol/L) and similar amount of AT1-R binding sitesapplication cannot be ruled out. To test this hypothesis,
in LMV and BLMV. In line with the previously reportedexperiments were repeated in the presence of 5 107
characteristics of AT1-R, [39, 44], we found in both LMVmol/L l-glutamate phosphonic acid (GluPO3H2), a po-
and BLMV firstly, that DTT (mmol/L range) exerts antent APA inhibitor [41], but poor inhibitor of APN [42].
inhibitory effect on radioligand binding; and secondly,APA inhibition allowed the prevention of the first step
that binding of [Sar1, Ile8]-Ang II was inhibited by losar-of the major Ang II degradation pathway. Previous ex-
tan, a selective AT1-R antagonist, but was not affectedperiments performed in our laboratory with LMV prepa-
rations established that at that concentration, the Glu- by two distinct AT2-R antagonists. These binding studies
were further supported by immunoblot experiments withPO3H2 inhibits luminal APA activities in mTAL (95%).
As shown in Figure 7, in the presence of GluPO3H2 the AT1-R specific antibody, showing similar expression of
AT1-R protein in LMV and BLMV preparations.luminal application of 107 mol/L Ang II had no effect
on intracellular Ca2, as previously observed in the ab- The presence of similar amounts AT1-R binding sites
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and similar expression AT1-R protein in both BLMV in the kidney and thus may be efficient at far lower values
than Km, as previously reported for other peptidases. Forand LMV cannot be explained by a cross contamination.
First, BLMV and LMV were largely purified, as indicated example, angiotensin converting enzyme has a Km for
Ang I (16 mol/L) that is far higher than the pmol/Lby the high enrichment of LMV with -glutamyl trans-
ferase activity (LM marker) and of BLMV with Na, circulating concentrations of its substrate [50].
The selective presence of APA and APN at the lumi-K-ATPase activity (BLM marker) as detailed in the
Methods section. Since AT1-R have been functionally nal membrane of mTAL suggest that APA and APN
activities may play an important role in modulating thedemonstrated in basolateral membrane after bath addi-
tion of Ang II in the in vitro microperfused of mTAL activity of intratubular endogenous Ang II in this tubule
segment. Consistent with this proposition, Ang II is[45], the main problem might arise from potential con-
tamination of LMV with BLMV AT1-R. This possibility, found in distal tubule and final urine, which confirms the
presence of endogenous Ang II in the lumen of mTALhowever, is very unlikely since LMV was de-enriched in
Na,K-ATPase activity. In addition, we have previously in vivo [51, 52]. Parenthetically, the surprising absence
of effect on HCO3 absorption of Ang II added to the per-shown, using the same preparations in immunoblot ex-
periments, that several transporter proteins present in fusate solution of in vitro microperfused mTAL might
be explained by the very low perfusion rate (0.5 nL/min)BLMV (that is, AE-2, NHE-1 and NHE-4) were not
detected in LMV [26, 30, 31]. used in the latter experiments (compared to the 10 times
higher tubular fluid rates in free flow situations), whichAminopeptidases A (APA) and N (APN) are ecto-
enzymes responsible for the conversion of Ang II to may allow complete degradation of perfused Ang II [45].
Finally, previous experiments in microdissected mTALAng III, and of Ang III to Ang IV, respectively. APA
is generally considered as the limiting step for Ang II segments have shown that Ang II induces an increase
in intracellular Ca2, as generally expected from Ang IIhydrolysis [46]. Northern blot hybridization and immu-
noblot analyses have localized APA expression at glo- stimulation of AT1-R [20]. In the present study, in the
mTAL suspensions used as starting material for simulta-merular mesangial and epithelial cells, and proximal tu-
bule cells in rats [47, 48]. However, a recent study in rat neous preparation of LMV and BLMV, we confirm that
Ang II added in the medium also induced the [Ca2]i re-microdissected nephron segments has shown that APA
activity is present all along the nephron, with higher sponse. The Ang II concentration-dependent [Ca2]i peak
response displayed a half maximal response (EC50) forenzymatic activity in glomerulus and proximal tubule
[23]. In the proximal tubule APA and APN are selec- 1.2 nmol/L Ang II, a value similar to the Kd of Ang II
binding to basolateral membranes. Note that in proximaltively localized in BBM, but the subcellular localization
of APA and APN in more distal segments is not known. tubule, the EC50 values for Ang II concentration-depen-
dent [Ca2]i peak response and Ang II binding in basolat-The question is important in mTAL. Indeed, Ang III
has an effect similar to Ang II via AT1-R, and Ang IV eral membranes also are reported in nmol/L range [15].
Moreover, the present study provides arguments formight have effects opposite to Ang II on NaCl absorption
in renal tubule [25] via AT4-R present in mTAL (ab- the presence of distinct signal transduction pathways
coupled to mTAL luminal and basolateral AT1-R acti-stract; Poumarat et al, J Am Soc Nephrol 12:A2990,
2001). vated by Ang II. The in vitro microperfused mTAL ex-
periments show that the bath application of Ang II in-Our preparation of isolated LMV and BLMV, and the
availability of highly selective APA inhibitor EC-33 [34], duces an acute mobilization of intracellular Ca2 pool.
By contrast, the addition of Ang II to the luminal solutionoffered the opportunity to localize membrane-bound
aminopeptidase activities in mTAL. We show clearly perfused at very high rate (20 nL/min), and in the pres-
ence of an inhibitor of APA, GluPO3H2 [42], two condi-that APA and APN activities are selectively localized at
the luminal side of mTAL epithelium, as in the proximal tions that largely reduced the APA degradation rate,
has no effect on [Ca2]i. Altogether, our results suggesttubule. APA and APN activities in LMV are 10 and 5
times lower than in BBM, respectively, and APA activi- that basolateral but not luminal AT1-R are coupled to
calcium signal transduction pathways in mTAL.ties are functionally identical in LMV and BBM.
It should be noted that we found a Km value for the This observation was not unexpected because an asym-
metric coupling of AT1-R to transduction pathways al-synthetic substrate of APA of about 100 mol/L, a value
far higher than the intratubular nanomolar concentration ready has been observed in the proximal tubule. Indeed,
in proximal tubule suspension and microdissected seg-of the physiologic substrate Ang II measured at the end
of the proximal tubule accessible in vivo [6]. The recently ments, Ang II induces intracellular Ca2 mobilization
independently of the presence of calcium [15]. However,measured Km value of APA for Ang II is similarly high
about 70 mol/L [49]. However, the kinetic parameters in the proximal tubule BBM, Ang II does not activate
PLC activity but activates PLA2, independently of theof APA are likely compatible with hydrolysis of Ang II
in vivo. Indeed, like APN, APA is present in large excess presence of Ca2, and stimulates the Na/H exchange via
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modulates rat proximal tubule transport. J Clin Invest 97:2878–this pathway with a similar nmol/L range EC50 [18]. Fur- 2882, 1996
thermore, luminally added PLA2 inhibitors blunt Ang II- 9. Liu F, Cogan M: Role of angiotensin II in glomerulotubular bal-
ance. Am J Physiol 259:F72–F79, 1990mediated fluid absorption, while basolaterally added in-
10. Tank J, Moe O, Star R, Henrich W: Differential regulation ofhibitors have no effect in the in vitro microperfused
rat glomerular and proximal tubular renin mRNA following uni-
proximal tubule [53]. In LLC-PK cells transfected with nephrectomy. Am J Physiol 270:F776–F783, 1996
11. Paxton W, Runge M, Horaist C, et al: ImmunohistochemicalAT1-R cDNA, apical, but not basolateral Ang II, stimu-
localization of rat angiotensin II AT1 receptor. Am J Physiol 264:lates PLA2 independently of Ca2. In addition, the apical F989–F995, 1993
Ang II-AT1-R complex displays a high rate of endocyto- 12. Brown G, Douglas J: Angiotensin II binding sites on isolated rat
renal brush border membranes. Endocrinology 111:1830–1836, 1982sis and recycling, which is PLA2-dependent and conco-
13. Brown G, Douglas J: Angiotensin II-binding sites in rat andmitant with occurrence of transepithelial sodium flux
primate isolated renal tubular basolateral membranes. Endocrinol-
[16, 17]. The modulation of cytoskeleton microtubule ogy 112:2007–2014, 1983
14. Edwards R, Aiyar N: Angiotensin II receptor subtypes in theor actin organization may offer an additional mode of
kidney. J Am Soc Nephrol 3:1643–1652, 1993regulation of activity of endogenous Ang II [54]. Further
15. Poggioli J, Lazar G, Houillier P, et al: Effects of angiotensin II
studies are necessary to determine whether luminal and nonpeptide receptor antagonists on transduction pathways in
rat proximal tubule. Am J Physiol 263:C750–C758, 1992AT1-R in mTAL also are coupled to calcium-indepen-
16. Becker B, Cheng H, Burns K, Harris R: Polarized rabbit typedent stimulation of PLA2 activity, and if it displays endo- 1 angiotensin II receptors manifest differential rates of endocytosis
cytosis and recycling. and recycling. Am J Physiol 269:C1048–C1056, 1995
17. Becker B, Cheng H, Harris R: Apical ANG II-stimulated PLA2In conclusion, the colocalization of AT1-R, APA and
activity and Na flux: A potential role for Ca2-independent PLA2.APN at the luminal surface of mTAL suggests that this
Am J Physiol 273:F554–F562, 1997
tubule segment is likely an important target site for the 18. Morduchowicz G, Sheikh Hamad D, Dwyer B, et al: Angiotensin
II directly increases rabbit renal brush-border membrane sodiumintrarenal endogenous renin-angiotensin system. The
transport: Presence of local signal transduction system. J MembrAPA/APN activities (which participate in the control of
Biol 122:43–53, 1991
the luminal concentrations of Ang II and of its metabo- 19. Mujais S, Kauffman S, Katz A: Angiotensin II binding sites
in individual segments of the rat nephron. J Clin Invest 77:315–lites), the density of luminal AT1-R, and AT4-R may
318, 1986modulate the net effect of intratubular Ang II on NaCl
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